Novartis AG (Novartis AG) Interest Expense : $-884 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Novartis AG's interest expense for the three months ended in Mar. 2024 was $ -221 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-884 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Novartis AG's Operating Income for the three months ended in Mar. 2024 was $ 3,373 Mil. Novartis AG's Interest Expense for the three months ended in Mar. 2024 was $ -221 Mil. Novartis AG's Interest Coverage for the quarter that ended in Mar. 2024 was 15.26. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Novartis AG Interest Expense Historical Data

The historical data trend for Novartis AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Interest Expense Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-850.00

-869.00

-787.00

-800.00

-855.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-200.00	-224.00	-222.00	-217.00	-221.00

Novartis AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-884 Mil.

Novartis AG (OTCPK:NVSEF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Novartis AG's Interest Expense for the three months ended in Mar. 2024 was $-221 Mil. Its Operating Income for the three months ended in Mar. 2024 was $3,373 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $18,720 Mil.

Novartis AG's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	3373	/	-221
	=	15.26

The higher the ratio, the stronger the company's financial strength is.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.